Polysubstance abuse ICD-10: why F19 is usually wrong

In this article▾

1. What is the polysubstance abuse ICD-10 code?
2. Why is F19 usually the wrong choice?
3. What the research found about the word
4. Common reasons why F-19 claims are rejected
5. How do you code someone using four substances?
6. What to write instead
7. What it costs to code all substances together
8. How Supa keeps the substance history intact
9. FAQ

TL;DR: Polysubstance is a word most of us were trained to use and DSM-5 retired in 2013. In ICD-10 it maps to F19, which means other or unknown substances. If you can name what your client is using, F19 throws that information away, and the record is poorer for it.

Key takeaways

• What is the polysubstance abuse ICD-10 code?
• Why F19 is usually the wrong choice
• What the research found about the word "polysubstance"
• Common reasons F-19 claims get rejected
• How to code someone using four substances
• What to write instead

Walk through any detox admission chart and you'll find the word polysubstance. It's fast to write, immediately understood by every colleague, and almost useless to anyone reading the chart later.

That's not a criticism of the clinicians writing it. Most of us learned the term when it was current, and it's still the most efficient way to say a true thing in one word.

What is the polysubstance abuse ICD-10 code?

The nearest thing is F19, which ICD-10-CM titles other psychoactive substance related disorders. It follows the same structure as the rest of the block, so F19.10 is abuse uncomplicated and F19.20 is dependence uncomplicated.

The name is the important part. F19 covers substances that are other or unknown, and it exists to catch what the nine specific categories cannot. It was never designed as a container for several identified drugs.

What F19 is actually for. Substances outside the named categories, and cases where the record genuinely cannot establish what someone took. Not a list of known substances that happens to be long.

Why is F19 usually the wrong choice?

Because you almost always know. Intake collected a substance history, the screen came back, and you documented it. Once the chart names alcohol, heroin, and cocaine, the specific codes exist and the general one no longer applies.

Coding F19.20 for that person does two things. It tells the record less than you knew, and it makes your careful assessment look like a chart nobody read.

There's a clinical cost as well as a billing one. An opioid-dependent client in withdrawal needs different management from a cannabis-dependent one, and F19 erases the difference for whoever picks up the case next. The next clinician inherits a code that tells them nothing.

What the research found about the word

Researchers at one health system looked at how often clinicians reached for it. In a single year, clinicians selected a "polysubstance" diagnostic phrase in over 87,000 patient encounters, which was 3.4% of all encounters system-wide, and none of those phrases described which substances were involved (Journal of General Internal Medicine, 2022).

The authors were direct about what gets lost. The imprecise term omits diagnostic and substance use details that could have guided treatment decisions, because different substance combinations need different clinical interventions (Journal of General Internal Medicine, 2022).

DSM-5 removed polysubstance in 2013 (Journal of General Internal Medicine, 2022). The term has been retired for over a decade and survives because it is genuinely convenient and because it is still sitting in most EHR dropdowns.

Common reasons why F-19 claims are rejected

Selecting it because it seems appropriate. This is the big one, and it's not a clinician failing. If "polysubstance dependence" appears in your diagnosis picklist, busy people will select it, because it's there and it's true enough. Removing it from the list does more than any training session.

Using F19 when intake didn't know complete history. Reasonable on day one. The problem is nobody returns to update it on day two when toxicology resolves the question.

Assuming multiple substances means one combined code. The hierarchy rule limits you to one code per substance at the highest severity. It says nothing about how many different substances you may report.

Naming substances in the narrative but not the diagnosis. Your assessment lists four substances beautifully and the diagnosis field carries F19.20. The narrative isn't what travels with the claim.

Treating specificity as pedantry. It's the opposite. Coding each substance is how the next clinician knows what they're walking into.

How do you code someone using four substances?

Four codes, one per substance, each at the severity you documented.

Within any one row, the hierarchy still binds. If the chart says the client was both abused and depended on alcohol, only the dependence code goes on the claim (American Medical Coding).

The practical test is a single question. Can you name it? Then code it. F19 is for the genuinely unidentifiable, which is rarer than most charts suggest.

What to write instead

The fix is in the assessment line, and it's not longer than what you were writing.

Weak: "Polysubstance dependence."

Better: "Alcohol dependence, daily use. Opioid dependence, IV heroin, withdrawal present on admission. Cocaine abuse, weekend pattern. Nicotine dependence, cigarettes."

That version takes about the same time to write and does considerably more work. It tells the next clinician what to expect, it supports the level of care, and it means nobody has to guess later which substance was driving the admission.

What it costs to code all substances together

Diagnosis problems rarely announce themselves as diagnosis problems. Insurers denied 19% of in-network claims on marketplace plans in 2024, with rates as high as 36% at some insurers (KFF).

The specific trap with F19 is that whoever handles your prior authorizations may have obtained approval by discussing an opioid dependence diagnosis on the phone, while the claim went out under F19.20. The service was authorized. The claim wasn't, at least not as billed.

Fewer than 1% of denied claims were appealed in 2024, and 66% of the appeals filed were upheld in the insurer's favor (KFF). None of that reaches you as a denial. It reaches you as a request for records.

How Supa keeps the substance history intact

The current problem is that your intake team collects a detailed history and it gets compressed into one imprecise code somewhere between the assessment and the claim, where it becomes a denial nobody traces back. Nobody does it on purpose. It just happens.

Supa runs inside the systems you already use. When intake documents four substances and the diagnosis field carries F19.20, that gap surfaces before the chart closes. It also notices unspecified codes left in place after toxicology was resolved, and diagnoses that stopped matching the narrative weeks ago.

It doesn't diagnose. It notices when the record says less than you already established, which is the specific thing F19 does.

If polysubstance appears on more than a handful of your admissions, it is worth an hour. Book a demo and we will look at your intake records together.

FAQ

Q: What is the ICD-10 code for polysubstance abuse?

A: F19.10 is other psychoactive substance abuse and F19.20 is dependence. Neither is intended for clients using multiple identified substances. When you can name them, code each one with its own specific F code.

Q: Can I use F19.20 for someone using alcohol and opioids?

A: You should not. Both substances have their own categories, so the correct chart carries F10.20 and F11.20. Using F19 discards the severity detail that supports the care you're recommending.

Q: Is polysubstance dependence still a diagnosis?

A: Not in DSM-5, which removed it in 2013 in favor of diagnosing each substance use disorder separately. The term survives in EHR templates and clinical shorthand, which is why it keeps reaching claims.

Q: How many substance codes can I put on one chart?

A: As many as you documented, one per substance. The hierarchy rule restricts you to a single code per substance at the highest severity recorded, and places no limit on the number of substances.

Q: What if we genuinely don't know what they took?

A: F19 is correct in that moment. Build a habit of revisiting the diagnosis once toxicology returns, because an unspecified code left in place after the substance is identified is the version that causes problems.

Q: Why does it matter clinically, not just for billing?

A: Because the next clinician reads the code. Alcohol withdrawal and stimulant withdrawal need different management, and a chart that says polysubstance gives whoever picks up the case no way to prepare. The same specificity problem shows up across behavioral health billing.